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Summagy 
We have demonstrated Th2 clonal anergy as  a  consequence of partial  T  cell activation by 
immunogenic peptide and chemically fixed APC, as well as by altered peptide ligand and live 
antigen-presenting cells (APC). Either stimulation resulted in a profound inability of the T cells 
to proliferate  upon restimulation with antigen and functional APC, a similar phenomenon to 
that found with Thl cells. The anergic state was long lasting and was restricted to proliferation, 
since the T cells retained the ability to produce cytokines upon restimulation, albeit at slightly 
reduced levels. Th2 anergy induction was inhibited by cyclosporine A, but not by provision of 
exogenous costimulation or growth factors. The data presented unify Thl and Th2 cells with 
regard to anergy and suggest that the fundamental control during anergy for both subsets is 
prevention of donal expansion, thus blocking amplification of the immune response. 
C 
D4  T cells require TCR engagement by an immuno- 
genic peptide bound to a class II MHC molecule, as 
well as a costimulus provided by the APC, for successful ac- 
tivation leading to clonal expansion (1, 2). Although the na- 
ture of the costimulus has not been completely elucidated, 
substantial evidence has accumulated implicating the B7-CD28 
interaction in the Thl subset (3), whereas IL-1 has been shown 
to have costimulatory activity for Th2 cells (4-7). In the Thl 
subset, it  has been dearly shown that TCR engagement 
without costimulation does not provide adequate signaling 
to induce proliferation (8-10). Interestingly, such an interac- 
tion leads to a state of profound unresponsiveness in these 
T  cells upon restimulation, a phenotype known as T  cell 
anergy (9-12). This unresponsive state appears to result from 
TCR triggering without T  cell proliferation (13) and can 
be prevented by providing exogenous costimulation during 
the initial TCR engagement (3, 14). More recently, we have 
demonstrated that stimulation of Thl dories with altered pep- 
tide ligands (APL)  1 and live APC, a combination that par- 
tially activates the T cells but does not induce proliferation, 
also results in unresponsiveness to future stimulation with 
the immunogenic peptide (15). Addition of exogenous co- 
stimulation does not prevent anergy from occurring in this 
situation, suggesting that a signaling event more proximal 
to the TCR is responsible for inducing unresponsiveness here 
(16). Although the intraceUular events involved are not yet 
1 Abbreviations used in this paper: APL, altered peptide ligands; ECD1, 
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide; HEL,  hen egg white 
lysozyme; RT, reverse transcriptase. 
revealed, it is clear that T cells of the Thl subset can be made 
functionally unresponsive for prolonged periods of time. 
In contrast to the extensive studies of Thl cell anergy, few 
investigations have been published that use similar protocols 
in the Th2 subset. From the limited data available, it has been 
generally accepted that Th2 cells are not susceptible to anergy 
induction after TCR occupancy without costimulation (2, 
17, 18). Moreover, anti-CD3 antibody induces unresponsive- 
ness to IL-2-driven proliferation in Thl but not Th2 clones 
(9), and anergy-inducing stimuli do not result in an auto- 
crine growth factor production defect in Th2 cells (19). Al- 
though the reason for this contrast in phenotype is unclear, 
one could ascribe it to the different intracellular signaling 
pathways activated after stimulation of the two T cell subsets, 
use of different costimulators or growth factors, or a combi- 
nation of these (5, 6, 20). One study has demonstrated a corre- 
lation between the presence of IL-4 and the resistance to toler- 
ance induction, both at the clonal level and in naive T cell 
populations (18). 
We reasoned that if anergy plays a significant  role in T 
cell tolerance,  then anergy should also be inducible in Th2 
cells. We decided to explore the susceptibility to tolerance 
induction of Thl and Th2 clones with identical antigen/MHC 
specificity,  namely,  Hb(64-76)/I-E  k.  We  have  previously 
shown that the Thl clones could be made anergic after pre- 
sentation of immunogenic peptide and chemically fixed APC 
or by presentation of APL and live APC (15). In this report 
we show the results obtained when analogous experiments 
were undertaken with the Th2 cells. Our data demonstrate 
that antigen presentation by chemically fixed APC does in- 
deed result in subsequent anergy of these Th2 cells to re- 
stimulation with functional APC and antigen. Moreover, we 
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APL, which stimulates cytokine production but not prolifer- 
ation, also results in an anergic phenotype upon restimula- 
tion with the immunogenic peptide. This extends our ear- 
lier observations with Thl clones to include Th2 clones and 
implies that the anergic state is important for both Thl and 
Th2 cells. 
Mat~riah and Methods 
M/c~  Female  CBA/J and B10.BR/SgSnJ  (referred  to as B10.BR) 
mice were purchased from National Cancer Institute (Bethesda, 
MD) or The Jackson Laboratory (Bar Harbor, ME) and used at 
5-10 wk of age. 
Ag and Antisera.  The Hbd(64-76) peptide, APL, and conal- 
bumin peptide were synthesized  with a RAMPS  apparatus (DuPont, 
W'Rmington, DE), purified  by reverse-phase  HPLC, and amino add 
content confirmed by analysis on an amino add analyzer (modal 
6300, Beckman, Palo  Alto, CA). APL is the name ascribed  to analogs 
of  immunogenic peptides in which the TCR contact residues have 
been manipuhted. These peptides do not stimulate T cell-prolifer- 
ative responses, but they do bind to the MHC molecules  with similar 
affinities as the wild-type peptide, stimulating some, but not all, 
TCR-mediated effector functions (16). The amino acid sequence 
for the Hb(64-76) peptide shown in the one-letter amino acid code 
is GKKVITAFNEGLK. The APL each contain a single amino add 
substitution; for example, the Asp73 APL contains an aspartate 
in place of glutamate at position 73. The amino acid sequence for 
the conalbumin peptide shown in the one-letter amino acid code 
is LLHWGAIEWEGIESG (21). mAb specific  for Ib2 (S4B6; 22), 
Ib4 (111311; American Type Culture Collection, Rockville, MD) 
and CD3e (23) were used as culture supernatants from the respec- 
tive hybridoma cell lines. 
Cell Lines.  We have previously described the generation and 
characterization of a pand of Fib-reactive Th clones, including 
the Th2 2.102 and EWSX clones (24). The Th clones were prop- 
agated on a 2-wk restimulation protocol by use of  irradiated (2,000 
tad) CBA/J splenocytes as a source of APC and endogenous an- 
tigen in R.PMI 1640 medium containing 10% fetal bovine serum 
(Hydone, Logan, UT), 2 mM ghtamine, 50/~g/ml gentamycin, 
Hepes buffer, 2-ME (2  x  10 -s M), and IL-2 (20 U/ml, superna- 
tants from P815 transfectants expressing the gene for routine I1r 
25). The T cell hybridoma, G2, was made by use of a standard 
fusion protocol with the Th2 clone, 2.102, (7 d after activation) 
and the c~-B- BW5147 fusion partner (26, 27). The Th2 clone 
D10 has been described dsewhere (28). It was propagated as de- 
scribed above, with conalbumin protein (100 #g/ml) as antigen. 
The CH27  B ceU lymphoma,  which  expresses H-2  k, BT,  and 
ICAM-1, was used as an APC source for the tolerance induction 
assays using live APC (27). 
Preparation of Fixed APC.  B10.BR  spleen cells were fixed by 
two different methods. The chemical cross-linker 1-ethyl-3-(3- 
dimethylaminopropyl)  carbodiimide (ECDI; Calbiochem-Behring 
Corp., La Jolla, CA) was used in the experiment shown in Fig. 
2 A only; paraformaldehyde  was used in all other experiments. For 
ECDI fixation, 10  s spleen cells were incubated for 1 h on ice in 
0.44 ml 0.9% NaC1 containing 75 mM ECDI, and then washed 
extensively. For paraformaldehyde  fixation, spleen cells (5  x  107 
cells/m1) were incubated in paraformaldehyde  (1% in HBSS) for 
10 min at room temperature, washed three times, incubated for 
30 min at 37~  in a 0.1-M lysine solution, and finally  washed three 
more times in HBSS. No differences  in the efficacy  of these two 
fixation protocols were observed. 
Pro//ferat/~  Assay~  The prolift~tive responses of the Th2 clones 
were performed in 96-well flat-bottomed plates in 200/~1 R.PMI 
1640 medium containing the clones (5  x  104 cells/well), irradi- 
ated or chemically fixed B10.BR spleen cells (2,000 tad, 5  x  10  s 
cells/well), and Hb(64-76) peptide (0-10/~M) or conalbumin pep- 
tide (0-316/zM). Wells were pulsed with [~H]TdR (0.4/~Ci/well) 
after 72 h of culture and harvested 18-24 h later. In some experi- 
ments, anti-II,2 (50/~l/well) or anti-IL-4 (25/~l/well) mAb cul- 
ture supernatants or murine rlL-l~ (50 pg/ml, a generous gift of 
David D. Chaplin, Washington University, St. Louis, MO) were 
added for the duration of the assay. 
Tolerance Induction AssaF.  Th2 cells (2.5-10  x  10  s cells/well) 
and fixed or irradiated B10.BR spleen cells (5  x  106 cells/well) 
were incubated at 37~  alone or with 10/~M Hb(64-76) peptide 
or 316/~M conalbumin peptide, either overnight (Fig. 2, A and 
C) or for the times indicated, in 24-well tissue culture plates in 
a final volume of I nil. T cells were then separated from APC as 
described (15), before  being challenged  in a proliferation  assay  using 
either 5  x  104 T cells/well and Hb(64-76) as antigen or anti- 
CD3e mAb (2Cll) culture supematant and Ib2 (20 U/ml). Where 
indicated, cyclosporine  A (1/~g/ml; Sandoz, Basel, Switzerhnd), 
rlL-1B (50 pg/ml), Ib2, or IL.-4  (20 tmits/ml) (25) were _~ld~  during 
the tolerance  induction stage. For tolerance  induction with live 
and  analog  peptides,  the  protocol  was  as  above, except that 
mitomycin C-treated (77/zl/ml, 90 min at 37~  CH27 B lym- 
phoma cells were used as APC (3  x  10s/well), and analog pep- 
tides were added as indicated (100/~M). 
Lymphokine Assays.  The lymphokine responses of the  Th2 
clones were assessed  by use of 24-h supernatants from cultures of 
proliferation assays. II.,4 was quantitated in a bioassay  as prolifera- 
tion of the II;,2/ID4-dependent CTLb2 cell line (29) or the IL-4- 
dependent 614 cell  line (a kind gift of  Osami l~na~awa, Washington 
University). Briefly, the cytokine-dependent cells (5 x  10Vwell) 
were incubated with test supematants (25/~1) for 48 h. [~H]TdR 
was included during the final 20 h. Where indicated, anti-Ib2 (50 
/~1) or anti-ID4 (25/~I) culture supernatants were also added for 
the duration of the bioassay. II.,3 was quantitated as proliferation 
of the ID3-dependent GG-1.12 cell line (30) and assayed  as above, 
with 104 GG-1.12 cells and 50-/~1 test supernatants. 
mRNA Detection.  Th clones and hybridomas (106 cells/well) 
were incubated in 24-well tissue culture phtes at 37~  alone, with 
immobilized anti-CD3e mAb (200/~l/well prebound for 6 h, then 
the excess washed off with I-IB$S), or with CH27 B lymphoma 
cells (3  x  10s/well) and 10/~M Hb(64-76) for 14 h, after which 
total RNA was extracted as described (31), and dissolved  in water. 
Cytokine mRNA was detected by reverse transcriptase (RT) of  the 
mRNA, followed by a PCR. First, strand cDNA was made in a 
20-/~1 reaction, by use of 1/~g of total RNA as temphte, an oligo- 
dT prime~ and the superscript RT enzyme (GIBCO BRL, Gaithers- 
burg, MD). The PCR (32) was then used to amplify cDNA of 
Ib2, IL-4, and the VB1 TCK chain by use ofa thermocycler (~m/~ 
Tronic; Thermolyne, Dubuque, IA). All oligonucleotide primers 
used to amplify cytokine cDNA span introns and the sequences 
and amplification conditions are provided dsewhere (33). Nucleo- 
tide sequences for primers used to amplify  VB1 cDNA are as follows: 
VB1 primer sequence  is 5'GTC~C,C"IGCAC,  C,  CT~- 
TCCT 3';  C~1 primer sequence is 5'GAGC~TAGCCTTTTG- 
TTTGTT'IGCAAT  3'  (a  gift  from  Kenneth  M.  Murphy, 
Washington University). All oligonucleotide primers were gener- 
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CA). Amplified bands were analyzed on 3% agarose gels (NuSieve; 
FMC Corp.,  Rockland, ME). 
Results 
Antigen Presentation by Chemically Fixed Splenocytes Does Not 
Activate Th2 CellProliferation.  Although presentation to Thl 
cells of an antigenic peptide by chemically fixed spleen cell 
APC does not support clonal expansion, reports suggest that 
Th2 cells can proliferate well to such a stimulus (17).  We 
decided to directly examine the Th2 response to antigen and 
fixed APC, since the published data suggested a striking differ- 
ence in activation requirements by the two Th cell subsets. 
The Th2 clone 2.102 recognizes the immunogenic peptide 
of the  murine  hemoglobin  fla  minor  chain,  Hb(64-76), 
bound to an I-E  t molecule, and has been exclusively charac- 
terized (24, 34). Irradiated B10.BR splenocytes and Hb(64- 
76) peptide stimulated a vigorous proliferative response from 
2.102 cells. In marked contrast, however, presentation of the 
immunogenic peptide by chemically fixed spleen cells did not 
induce any detectable proliferation from these T  cells (Fig. 
1 A). This phenotype was surprising since it differed from 
that reported for other Th2 clones (17). However, this lack 
of proliferation was not simply due to a shift in the antigen 
dose curve, since presentation of up to 100/~M peptide by 
these APC (>100-fold excess of the 50% maximal response 
using irradiated spleen cell APC) did not stimulate any clonal 
expansion of the 2.102 cells (data not shown). Whereas the 
signal delivered to the T cells by antigen and fixed APC was 
inadequate to stimulate proliferation, the amount of IL-4 pro- 
duced was normal (or only slightly decreased in some ex- 
periments), whereas IL-3 production was somewhat reduced 
(Fig.  1, B  and C).  This phenotype resembles that of Thl 
cell reactivity to antigen presentation by fixed APC, and there- 
fore suggests the absence of a costimulus that is required for 
proliferation and maximal IL-3 production,  but  not IL-4 
production. 
Antigen Presentation by Chemically Fixed Splenocytes Induces 
Anergy of Th2 Cells to Subsequent Stimulation with Functional 
APC.  The observation that chemically fixed APC failed to 
stimulate  Th2  cell proliferation,  but  supported  cytokine 
production, raised the possibility that antigen recognition 
in this way might lead to unresponsiveness in these T cells. 
To test this,  2.102  cells were preincubated overnight with 
chemically fixed B10.BR splenocytes, with or without an- 
tigen, and restimulated with fresh irradiated spleen cells and 
antigen. Whereas T  cells that had been preincubated with 
fixed APC alone were able to proliferate normally during the 
secondary stimulation, those that had been preincubated with 
fixed APC and antigen were almost completely unrespon- 
sive to restimulation with fresh spleen cells and antigen (Fig. 
2 A).  This inability to proliferate upon restimulation was 
a long-lasting phenotype, since the T cells remained unrespon- 
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Figure 1.  Th2 clone 2.102 proliferative  and cytokine  production re- 
sponses to Hb(64-76) pr-~nted by irradiated  or fixed  spleen cells. T cells 
(5 ￿  10Vwdl)  and irradiated  (2,000 tad) or paraformaldehyde-fi,~l  spleen 
cells (5  x  105/well)  were cultured with the indicated  doses of Hb(64- 
76) pc'pride. Proliferation  (A), IL.4 (B), and lit3 (C) production  wece  mea- 
sured as described  in Materials and Methods. Blocking  mAb specific  for 
IL-2 ($4B6, 50/tl/well) or II,4 (11Bll, 25/~l/wen) were added for the 
duration of the bioassay  in B. The points represent  the mean of triplicate 
cultures + SD. Each  experiment  is a representative  of  >8 independent  assays. 
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Figure  2.  Induction  of Th2 clonal anergy through  presentation of 
Hb(64-76) by chemically fixed splenocytes. Th2 cells (2.5  x  10S/wall) 
and irradiated APC or Th2 cells (10~/wdl) and fixed APC were incubated 
alone or with peptide (10 #M) overnight (.4 and C) or for 13 d (/3) to 
induce anergy. The T cells were then purified and challenged in a prolifer- 
ation assay using 5  ￿  104 T ceils/well and Hb(64-76) as antigen. Fresh, 
unmanipulated T cells were included in B as a control. The Th2 cells used 
for each experiment were 2.102 cells (.4 and B) and EWSX ceils (C). Cell 
recoveries after the anergy induction stage, expressed as a percentage of 
input cell number, were as follows: (A) 55% for no peptide group and 
57.5% for Hb(64-76) group; (B) 51.5% for fixed/Hb(64-76) group and 
223% for irradiated/Hb(64-76) group; and (C) 52.5% for no peptide group 
and 50% for Hb(64-76) group. The points represent the mean of triplicate 
(A and C) or duplicate (B) cultures :t: SD. Each experiment is a represen- 
tative from >10 (A), 4 (/3), or 7 (C) independent assays. 
sive 13  d  after the initial  stimulation  with  fixed APC  and 
antigen (Fig.  2 B). In contrast,  T  cells that had been prein- 
cubated with irradiated spleen cells and antigen proliferated 
as well as freshly isolated 2.102 cells at this timepoint (Fig. 
2 B). The observed lack of proliferation upon antigenic chal- 
lenge could not be explained by cell death,  since equivalent 
numbers of cells were recovered whether or not peptide was 
present during  the initial stimulus  with fixed APC  (Fig.  2 
legend). Moreover, both anergic and nonanergic Th2 cells could 
proliferate equivalently in response to exogenously added IL-2 
when combined with anti-CD3 mAb stimulation to upregu- 
late surface levels of the IL-2R, further indicating  that cell 
death did not  account  for the unresponsiveness  to antigen 
stimulation  in  the  anergic  T  cells  (Table  1). 
Th2 Cells Are Made Anergic after Stimulation by Altered Pep- 
tide Ligand and Live APC.  We have previously shown that 
stimulation  of Thl clones with live APC and APL,  which 
allows partial  T  cell activation but  not  proliferation,  leads 
Table  1.  Comparison of Proliferation of Anergic versus Nonanergic T  Cells to Antigen or Exogenous IL-2 
Preincubation  condition 
(with  fixed APC)  1 #M 
gestimulation  (cpm) 
Hb(64-76)/APC  anti-CD3e  +  IL-2 (20  U/ml) 
0.1  ~M  5 #1  2  #1 
No peptide  12,649  10,732  43,240  43,100 
Hb(64-76)  5,853  4,563  46,004  43,829 
2.102 cells (106/well) and fixed spleen cells were incubated overnight alone or with indicated peptide (10 #M). T  cells were then recovered and 
assayed for their ability to proliferate in response to peptide or exogenous IL-2. Anti-CD3  mAb was included with the IL-2 stimulus to upregulate 
cell surface levels of IL-2R, since the T cells from both groups responded poorly to IL-2 alone. Cell recoveries after anergy induction,  expressed 
as a percentage of input  cell number,  were 65%  for no peptide group  and 79% for Hb(64-76) group. 
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lation with fresh APC and immunogenic peptide (15). We 
wished to determine if this phenomenon could be extended 
to T cells of the Th2 phenotype. We have previously reported 
that 2.102 cells are stimulated to produce IL-4, but not to 
proliferate, when presented with the APL Asp73 and live APC 
(34). To explore the consequences of this partial activation, 
2.102 cells were stimulated overnight with live APC with 
or without the Asp73 analog.  The T  cells were then sepa- 
rated from the APC and restimulated with fresh APC and 
immunogenic  peptide. Whereas T cells previously incubated 
with APC alone or APC and the nonstimulatory peptide 
analog Ghi72 proliferated vigorously upon restimulation with 
the immunogenic peptide, 2.102 cells previously incubated 
with live APC and the Asp73 analog displayed an unrespon- 
sive phenotype when challenged with Hb(64-76)  (Fig. 3). 
These data therefore confirm that Th2 cells, which are sensi- 
tive to anergy induction by antigen presentation with chem- 
ically fixed APC, can be made anergic after partial activation 
by peptide analog and live APC. This extends our observa- 
tion of anergy induction with live APC and APL in Thl 
cells to include Th2 clones. 
It was important to determine if anergy could be extended 
to other Th2 clones, or if it was a unique property of 2.102 
cells. Thus, we examined the response ofEW5X, a Th2 clone 
with identical peptide/MHC specificity  as 2.102 but expressing 
a distinct TCR (Hsu, B.L., and P.M. Allen, unpublished ob- 
servations).  EW5X cells, like 2.102 cells, did not proliferate 
when presented with antigen by fixed APC while being stimu- 
lated to produce II.-4 and IL-3. After such an initial stimula- 
tion, EW5X cells displayed an anergic phenotype, being un- 
able to proliferate to live APC and immunogenic  peptide (Fig. 
2 C). Thus, the unresponsive state induced after antigen pre- 
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Figure 3.  Asp73 APL and live APC induce anergy of 2.102 Th2 cells. 
2.102 cells (10~/well) and mitomycin C-treated CH27 B lymphoma cells 
0  x  10S/well) were incubated  alone or with indicated peptide (100 ~M) 
for 20-24 h. T  cells were then separated from APC and challenged  in 
a proliferation  assay using 5  x  104 T  cells/well,  irradiated  spleen cells 
(5  x  10S/well), and Hb(64-76) at the indicated concentrations. Cell recov- 
eries after anergy induction, ~pressed as a percentage of cell input, were 
63 % for no peptide group, 93.5 % for Asp73 group, and 76.5 % for Gln72 
group.  Each point represents the mean of triplicate  cultures  +  SD. The 
e~periment  is a representative  of three independent assays. 
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sentation by chemically fixed APC could be shown for mul- 
tiple Th2 clones. 
It was also important to determine if our Th2 clones differ 
from those of others reported in the literature to be resistant 
to anergy induction (2), or if our protocol could render such 
T cells anergic. To address this issue, we examined the toler- 
ance susceptibility of the well-characterized  Th2 clone D10 
(28) under identical experimental conditions, using the conal- 
bumin immunogenic peptide (residues  132-146) as antigen 
(21). Like 2.102, D10 cells did not proliferate when presented 
with antigen by chemically fixed APC (Fig. 4 A). Upon anal- 
),sis of the cytokines produced, it was found that, whereas 
antigen presented by irradiated APC stimulated significant 
amounts of IL-3 and IL-4 by D10, antigen presentation by 
fixed APC failed to stimulate any detectable levels of either 
cytokine (Fig. 4 B and data not shown). Therefore, in con- 
trast to the phenotype observed with 2.102, D10 showed no 
indication of being partially activated by antigen and fixed 
APC. Moreover,  after such an initial stimulation, D10 calls 
were able to proliferate  normally when restimulated by an- 
tigen and irradiated APC, thus failing to display an anergic 
phenotype (Fig.  4 C).  These results were consistent with 
previous literature and led us to conclude that there must 
be a phenotypic difference between our Th2 clones and D10 
that accounts for the difference in tolerance susceptibility. 
Tke Anergic Tk2 Cells Can Still Make Cytokines upon Re- 
stimulation.  The observation that the Th2 clones were able 
to make cytokines in response to antigen presentation by fixed 
APC suggested that the signaling requirements for cytokine 
production and proliferation differ, with a fixation-sensitive 
component necessary only to activate proliferation. It was 
of interest to investigate if the anergic Th2 cells could still 
produce cytokines upon restimulation. To test this, 24-h su- 
pernatants were collected from the restimulation assay de- 
scribed in Fig. 2 and analyzed for cytokine production. In 
contrast to their inability to proliferate upon restimulation, 
we found that the anergic Th2 cells were still able to pro- 
duce IL-4 and IL-3, albeit at slightly reduced levels compared 
with unanergized Th2 cells (Pig.  5, A  and B). These data 
raise two interesting points.  First,  the signaling pathway 
leading to proliferation is distinct from that leading to cytokine 
production in Th2 cells, with only the proliferation pathway 
containing a component sensitive to inactivation. Second, 
anergic Th2 cells, unlike anergic Thl cells, retain the capacity 
to make their autocrine growth factor, but have lost the ability 
to respond to it. 
Th2 Anergl/ is Cydosporine  A Sensitiw  Since Thl anergy 
can be prevented if cyclosporine A is added with the anergy- 
inducing stimulus (14, 15), and since Th2 proliferation and 
1L-4 production can be inhibited by cyclosporine A (35, Sloan- 
Lancaster, J., unpublished observations), it was of interest 
to investigate if Th2 anergy was similarly sensitive to inhibi- 
tion by this drug. 2.102 cells were therefore preincubated with 
fixed APC and peptide with or without cyclosporine A and 
then analyzed for their ability to proliferate upon restimula- 
tion with fresh APC and antigen. As shown in Fig. 6, the 
addition of this drug to the preculture prevented the Th2 
cells from becoming anergic, indicating that Th2 anergy, like A  15000- 
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Figure 4.  Th2 clone D10 proliferative, cytokine  production, and anergy 
induction responses to conalbumin  peptide presented by irradiated or 
spleen cells. (.4 and B) T cells (5  x  104/we11)  and irradiated (2,000 fads) 
or paraformaldehyde-fixed  spleen cells (5  x  104/well) were cultured with 
the indicated doses of conalbumin peptide, and proliferation (A) or IL-3 
production (B) were measured as described in Materials and Methods. (C) 
T cells (104/we11) and fixed spleen cells (5  x  104/we11) were incubated 
alone or with conalbumin peptide (316 ~M) overnight to induce anergy. 
The T cells were then purified and challenged in a proliferation assay  using 
5 x  10  4 T cells/well and conalbumin protein as antigen at the indicated 
doses. The points represent the mean of triplicate cultures +_ SD. Each 
experiment is a representative from seven (A and C) or three (B) indepen- 
dent assays. 
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Thl anergy, is cydosporine A sensitive.  This observation sug- 
gests that the signaling pathway involved in Th2 cell anergy 
involves a calcineurin-dependent  step. 
Addition of  Exogenous Costimulation or Growth Factors Does 
Not Prevent Th2 Clonal Anergy.  Following the paradigm of 
Thl anergy by fixed APC, we examined the involvement of 
costimulation in Th2 anergy. IL-1 is well documented as a 
candidate costimulatory factor for Th2 cells (5-7). To deter- 
mine if this  cytokine was a costimulator for 2.102,  the re- 
sponse of these T  cells upon antigen presentation by fixed 
APC was compared with or without the addition of exoge- 
nous rlL-1B. Although fixed APC and antigen alone did not 
Figure 5.  Cytokine production of anergic Th2 cells upon restimula- 
don with antigen. 2.102 ceils were stimuhted as in Fig. 2 A, and superna- 
tams were collected  from the challenge assay  at 24 h and analyzed  for pres- 
ence of IL-4 (A) and IL3 (/3) by bioassay using the II.,4-dependent 614 
(A) or IL-3-dependent  GG-1.12 (B) cell lines. Cell recoveries after anergy 
induction stage, expressed as a percentage of  input cell number, were 40% 
for no peptide group and 44% for Hb(64-76) group. The points represent 
the mean of triplicate cultures + SD. Each experiment is a representative 
of three independent assays. 
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Figure 6.  Th2 anergy is prevented by cy~losporine A. 2.102 cells were 
used in the tolerance assay  as in Fig. 2 A, with the addition of cy~losporine 
A (1 ~tg/ml) to the indicated groups. T cells were then rested for 1 d be- 
fore being used in the challenge proliferation assay. Cell recoveries after 
the anergy induction stage, expressed  as a percentage of input cell  number, 
were 55.3% for no pepride group, 50% for Hb(64-76) group, 34.2% for 
no pepride/CsA group, and 47.4% for Hb(64-76)/CsA group. The points 
represent the mean of triplicate cultures •  SD. The experiment is a repre- 
sentative of four independent assays. 
stimulate proliferation,  addition  of IL-1 to this  culture  in- 
duced a proliferative response from the T  cells indistinguish- 
able from that  stimulated by antigen  and live APC  (Fig.  7 
A). This demonstrated  that IL-1 could be used by the Th2 
cells as a costimulus,  in an analogous manner to the use of 
CD28 by Thl cells. However, when the 2.102 cells with fixed 
APC and antigen plus IL-1 were then challenged with fresh 
APC and antigen,  the T  cells stiU displayed an unresponsive 
phenotype (Hg. 7/3). In contrast, 2.102 cells stimulated with 
irradiated APC and Hb(64-76) were capable of proliferating 
vigorously when restimulated with fresh APC and antigen 
(Hg.  7 B).  These results  led us to  conclude  that,  whereas 
IL-1 can substitute for the missing factor required  for Th2 
proliferation in response to antigen presentation by fixed APC, 
its absence in the initial culture is not responsible for indudng 
the anergic state.  This appears to be in contrast  to the role 
played by CD28 in the Thl system, where ligation of CD28 
is capable both of activating proliferation to antigen presented 
by fixed  APC  and  preventing  anergy induction  to  such  a 
stimulus (3, Sloan-Lancaster, J., unpublished  observations). 
Thus, it appears that we can induce an anergic state in a Th2 
cell when the stimulus it is provided allows the cell to pro- 
liferate: i.e.,  IL-1 as a costimulus is suffxient to restore prolifer- 
ation to but not to prevent anergy induction by antigen and 
fixed APC. Whether the anergic Th2 cells can recover from 
the unresponsive state if allowed to proliferate in the absence 
of antigen  was not addressed in this experiment.  We next 
investigated  the effect of adding  various growth  factors to 
the primary culture  with  antigen  and fixed APC  to assess 
their effect, if any, on the anergic state.  Addition  of exoge- 
nous IL-2 or IL-4 with antigen and fixed APC did not pre- 
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Fignre  7.  Th2 anergy is not ~ted  by addition of ~togenous co- 
stimulators or growth factors. (A) Proliftrarion of 2.102 cells to Hb(64- 
76) and irradiated or ftazd spleen cells •  rIbl~J (50 pg/ml). (B and C) 
Anergy induction in the presence of caogenous Ibl (B), Ib2, or Ib4 
(C). 2.102 cells (2.5  x  10S/well) and irradiated spleen cells, fax~ spleen 
cells plus rlDl~ (50 pg/ml), or 2.102 cells (104/well) and fixed spleen 
cells were incubated alone or with pepride (10 ~tM) for 13 d. Where indi- 
cated, either Ib2 or IL-4 (20 U/ml) were included. T cells were then re- 
co~red and challenged in a proliftrarion assay using 5  ￿  104 T calls/well 
and Hb(64-76) ix-pride to stimulate. Fresh unmaaipuhted T cells were 
added as a control in C. Cell recoveries  after the tolerance induction stage, 
expressed as a petr.entage of input cell number, were as follows: (B) 100% 
for irradiated/Hb  group, 65% for fixed/Hb group and 65% for fixed/ 
Hb/rII,1B group; (C) 54% for fi.,md/Hb/IL,4  group, 357% for irradiated/ 
Hb/Ib4 group, 91.5% for fixed/Hb/Ib2 group, and 380% for irradi- 
ated/Hb/Ib2 group. Each point represents the mean of triplicate (A) or 
duplicate (B and C) cultures  •  SD. Experiments are representatives of 
>10 (/1) and 4 (B and C) independent assays. 
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with live APC and antigen did not diminish the subsequent 
proliferative  response upon restimulation (Fig.  7 C). 
A study demonstrated that T cells of the Th0 phenotype 
could be made anergic after TCK engagement in the absence 
of costimulatory factors  (19). The anergic  phenotype was 
characterized by inhibition of IL-2 production and inability 
to proliferate while still producing IL-4.  Since some of the 
Th0 clones used in the study produced low levels of IL-2, 
we wanted to rule out the possibility that the 2.102 clone 
may be making low levels of IL-2. Using three different assays, 
we convincingly  demonstrated that 2.102 T cells do not make 
IL-2 and are bona fide Th2 cells. First, to examine the growth 
factor dependence of 2.102, blocking mAbs specific for IL-2 
or IL-4 were added to the culture during a proliferation assay. 
Whereas the anti-IL-4 mAb inhibited the proliferation of 
2.102 completely, anti-IL-2 mAb failed to diminish the re- 
sponse (Fig. 8 A). Second, supematant from activated 2.102 
cells could support the growth of the CTLL cell line, which 
was completely inhibited by anti-IL-4 mAb (Fig.  1 B).  Fi- 
nally, analysis by RT-PCR of the cytokine mRNA present 
after stimulation of 2.102, with either peptide/APC or anti- 
CD3 mAb, revealed an activation-dependent  synthesis of IL-4 
mRNA but no detectable IL-2 mRNA (Fig. 8 B). In con- 
trast, the T  cell hybridoma G2, made from a fusion of the 
2.102 clone, produced detectable IL-2 and IL-4 mRNAs upon 
activation, consistent with the detection of IL-2 protein from 
this hybridoma by bioassay (Fig. 8 B). Moreover,  when the 
mRNA synthesis pattern of a lysozyme-specific Th0 clone 
(Yule, T. D., and P. M. Allen, unpublished observations) was 
analyzed, constitutive IL-4 mRNA and activation-dependent 
IL-2 mRNA patterns were found (data not shown). In sum- 
mary, these data confirm that 2.102 is a Th2 done, since no 
IL-2 dependence or detection of IL-2 production by these 
T  cells could be demonstrated. 
Figure  8.  Th2 clone 2.102 does not require 1I.-2 to proliferate or pro- 
duce Ib2 upon stimulation. (A) Proliferation of 2.102 cells to Hb(64-76) 
and irradiated spleen cells. Blocking mAbs specific  for IL-2  ($4B6, 50 #l/well) 
or 1I--4 (11b11, 25 #l/well) were included in the indicated wells for the 
duration of the assay. Data points represent the mean of triplicate  cultures 
+  SD. (B) Detection by RT-PCR of Ib4 (lanes 3-8,  upper panel), IL-2 
(lanes 9-14), or VB1 (lanes 3-8, lower  panel) mRNA in 2.102 and G2 cells 
after various  stimuli. (Lanes 3  and 9) unstimulated 2.102;  (lanes 4 and 
10) anti-CD3-stimulated  2.102; (lanes  5 and 11) Hb(64-76)-stimulated 2.102; 
(lanes 6 and 12) unstimulated G2; (lanes 7 and 13) anti-CD3-stimulated 
G2; (lanes 8 and 14) Hb(64-76)-stimulated G2. Sizes of amplified PCK 
products are 188 bp (IL-4), 167 bp (II.-2), and 515 bp (VB1). Each e~peri- 
ment is a representative  of three (A) and five (B) independent assays. 
Discussion 
This report demonstrates that Th2 clones, similar to Thl 
cells, are susceptible to anergy induction in vitro. Specifically, 
we show that ddivery of an initial incomplete signal, which 
allows cytokine production in the absence of clonal expan- 
sion, results in a profoundly tolerant state. The phenotype 
of tolerant Th2 cells resembles that of anergic Thl cells in 
several ways. These include an inability to proliferate  in an 
antigen-specific manner while still able to divide if provided 
exogenous IL-2 (10, 15), maintenance of the ability to pro- 
duce cytokines and exert effector functions (2, 36, and Sloan- 
Lancaster, J., unpublished observations), and susceptibility 
of the anergy induction pathway to cydosporine A (14, 15). 
Furthermore, the anergic phenotype for both T cell subsets 
appears to be a long-lived state (10, 15). These observations 
unify Thl and Th2 cells with regard to anergy and suggest 
that inhibition of proliferation is the fundamental control 
mechanism used for anergy for both T  cell subsets.  This 
prevention of donal  expansion is  therefore an  important 
pathway for controlling amplification of the immune  response. 
Although there are many similarities  in the phenotypes 
of tolerant Thl and Th2 cells, there are also some striking 
differences. First, anergic Th2 cells retain the capacity to make 
their autocrine growth factor, but they have lost the ability 
to respond to it. The hallmark of Thl anergy is that the cells 
are unable to make IL-2 upon restimulation, yet provision 
of exogenous IL-2 activates vigorous proliferation (10). This 
indicates  that anergic  Thl cells have normal expression  of 
functional IL-2R, and that their defect is in the ability to 
synthesize the autocrine growth factor. In contrast, the anergic 
Th2 cells described here retain the ability to synthesize IL-4, 
but no longer proliferate to it.  This phenotype might be 
achieved by a downregulation of surface IL-4R or a func- 
tional uncoupling of the IL-4R from its intracellular signaling 
pathway. Alternatively, the inability to proliferate in the pres- 
ence of sufficient IL-4 may reflect a defect or absence of a 
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support of this, several studies have shown that TCR engage- 
ment can activate IL-4 production without inducing Th2 cell 
proliferation (28,  34).  The different phenotypes of anergy 
in the two call subsets may reflect different stringencies of 
regulation of the genes encoding their respective  growth 
factors, since several studies indicate that IL-2, but not IL-4, 
gene activation requires  costimulation in addition to TCR 
engagement (4, 6, 37).  Thus, Th2 cells may have evolved 
a mechanism to become unresponsive that does not involve 
the inactivation of their autocrine growth factor. 
Second, the two Th subsets differ in that the addition of 
exogenous costimulation does not prevent Th2 anergy in- 
duced by chemically fixed APC (10). Ahhough IL-1 func- 
tions as a costimulatory factor for some Th2 cells (5-7; Fig. 
7 A), it had no effect on the anergy induction for 2.102 (Fig. 
7 B). This observation indicates that exogenous IL-1 is not 
the natural costimulation utilized by these T calls and ulti- 
mately required by them to continually expand. Intrigningly, 
a recent report has demonstrated that CD28 can function 
as a costimulator for Th2 clones, presumably by inducing 
endogenous IL-1 production from the T cells (38). It is thus 
conceivable that the source of IL-1 in the system may be crit- 
ical, such that lack of endogenous T cell IL-1 gene activation 
during TCR engagement leads to subsequent anergy.  Al- 
though our initial studies indicate that CD28 activation does 
not prevent anergy of our Th2 ceils (Sloan-Lancaster, J., un- 
published observations), some other receptor-ligand inter- 
action (e.g., CTLA4-B7-1, -B7-2) may provide such a func- 
tion to allow endogenous T  cell IL-1 production (39-44). 
Our previous studies demonstrated that Thl clones could 
be made tolerant by presentation of an APL and live APC 
(15). The phenotype of this tolerant state apparently differs 
from that induced after antigen presentation with fixed APC, 
since only in the latter situation can anergy be prevented by 
addition of exogenous costimulation (14). In this report, we 
demonstrate Th2 anergy induced both by antigen presenta- 
tion with fixed APC and by APL presentation with live APC. 
Ahhough our initial studies indicate that the anergic pheno- 
type resulting from either stimulation appears to be the same, 
further  investigation must be  undertaken  to  assess this. 
Moreover,  the relationship between the signals involved in 
Thl and Th2 anergy is unknown at this point. 
Several studies have previously demonstrated a failure to 
tolerize Th2 clones (17, 18). Several potential variables may 
account for these different experimental findings. These could 
include the individual antigen specificities, costimulatory de- 
pendencies,  and level of maturity of the various cells used 
in the studies.  In support of this, Th0 cells are susceptible 
to tolerance induction, losing the ability to produce IL-2 and 
proliferate while still able to produce IL-4 (19). The pheno- 
type of these T  cells is similar to that of our Th2 clones, 
in that they lose the ability to respond to IL-4. Moreover, 
a recent study has demonstrated tolerance induction in vivo, 
in both the Thl- and Th2-like subpopulations (45). It is ar- 
gued that the precursors of the Th2 cells, rather than the 
mature Th2 cells themselves, are susceptible to tolerance in- 
duction in this case. It is possible that the Th2 population 
is less vulnerable to anergy signals than the Thl population, 
and that this resistance becomes more prominent as the ceUs 
progress in their lineage. One could imagine that established 
T call clones can represent ceils at different levels of matu- 
rity, a reflection of which cell lineage stage the precursor had 
progressed to when it was cloned. Thus, Th2 clones  that 
are susceptible to tolerance-inducing stimuli, while still ex- 
erting a defined Th2 phenotype (Fig. 1 B and Fig. 8), would 
represent ceils closer in lineage to Th0 cells than tolerance- 
resistant Th2 cells (Hg. 4). A comparison of the phenotypes 
of representatives from the two respective populations could 
potentially provide insight into this possibility. 
If a peripheral tolerance system is designed to deal with 
sdf-antigen-spedfic T cells that have escaped thymic toler- 
ance, all T  cell populations should be included for it to be 
efficient. To date,  Th0, Thl, and CD8 + T  cells have been 
shown to become anergic (10, 19, 46). Thus, it is reasonable 
to assume that Th2 ceils would also be susceptible to in vitro 
tolerance induction. Although unable to proliferate, anergic 
T  cells retain  the ability to  produce significant  levels of 
cytokines and carry out effector functions upon restimula- 
tion. Specifically, anergic Thl, Th0, and Th2 ceUs still make 
cytokines (2, 19, and data shown here), whereas anergic Thl 
cells and CD8 + T  cells retain cytolytic function (36,  46). 
These observations raise the question of the efficacy, and there- 
fore relevance, of functional anergy in an in vivo setting. How- 
ever, the immune system depends greatly on donal expan- 
sion for amplification of any response to become effective in 
a local environment. We propose, therefore, that the abla- 
tion of this ability by T cells is a highly efficient way of con- 
trolling an autoimmune response in vivo. In support of this, 
a similar T cell phenotype was found in a system using hen 
egg white lysozyme (HEL) as a neo-self-antigen. T cell clones 
generated from HEL-tnnsgeuic mice displayed  poorer prolifer- 
ation, but equivalent cytokine production profiles, when com- 
pared with T  call clones generated from nontransgenic lit- 
termates  (47).  The  transgenic  mice showed no  signs of 
autoreactivity, but displayed in vivo tolerance to the neo-self- 
antigen, demonstrating that limitation of donal expansion 
is sufficient for the control of an autoimmune response.  In 
summary, this report demonstrates that Th2 cells, like all 
other T cell clonal populations, are susceptible to anergy in- 
duction in vitro, and implicates an involvement of these cells 
during control of self-reactive lymphocytes in vivo. 
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